On Monday and Tuesday 13-14 December 2021, our consortium is holding its M12 consortium meeting, at the presence of representatives of all consortium partners, namely Charité – Universitätsmedizin Berlin (CHA – Coordinator), Lynkeus (LYN), Biotronik (BIO), European Clinical Research Infrastructure Network (ECRIN), Institut für Höhere Studien – Institute for Advanced Studies (IHS), Institut für Implantat Technologie und Biomaterialien e.V. (IIB), Philips Electronics Netherlands B.V. (PHI), Technische Universität Eindhoven (TUE), Technical University Graz (TU Graz), Universitatea Transilvania Din Bra?ov (UTBV), University College of London (UCL), Virtual Physiological Human Institute for Integrative Biomedical Research VZW (VPH Institute). The meeting will present an overview of all the activities performed in this first year of implementation, discuss the status of advancement of project R&D activities, as well as next steps and action items for the following months, in view of the Midterm Review with the European Commission, to be held in June 2022.
Besides results presentation from all WP Leaders, the meeting will include several collective discussion sessions concerning key aspects of the current implementation and relevant open issues:
- Data collection and processing collective session: discussing the status of data collection in the Virtual Research Environment (VRE) Drive and the data processing activities, in order to provide a suitable initial data pool for virtual cohort generation and modelling activities;
- Data management and GDPR compliance: discussing the status on legal agreements to be put in place between data providers (CHA, UCL) and modelling partners, in collaboration with clinical centres legal departments and their Data Protection Officers;
- Virtual cohort generation collective session: discussing the status of virtual cohort generation activities and open issues;
- Virtual device modelling collective session: discussing the status of preliminary device and anatomical model development and open challenges.